Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Wolozin

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2011
Local RNA translation at the synapse and in diseaseLiqun Liu-Yesucevitz, Gary J Bassell, Aaron D Gitler, et al.
Cellular Signalling|January 16, 2010
Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathwayIria Carballo-Carbajal, Susanne Weber-Endress, Giorgio Rovelli, et al.
Nature Communications|January 13, 2016
Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's diseaseQingde Zhou, Allen Yen, Grzegorz Rymarczyk, et al.
Molecular Neurodegeneration|March 20, 2008
Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor proteinCelina V Zerbinatti, Joanna M Cordy, Ci-Di Chen, et al.
Science Advances|February 1, 2023
Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stressLulu Jiang, Pijush Chakraborty, Lushuang Zhang, et al.
Frontiers in Neuroscience|April 25, 2020
Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in TauopathyChelsey Jenna LeBlang, Maria Medalla, Nicholas William Nicoletti, et al.
Neuron|December 24, 2002
Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neuronsLeonard Petrucelli, Casey O'Farrell, Paul J Lockhart, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2024
GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease-like filamentsPijush Chakraborty, Alain Ibáñez de Opakua, Jeffrey A Purslow, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Nanobodies targeting hnRNPA2/B1 and tauAzady Pirhanov, Cristian Rodriguez, Fatemeh Tashakori-Asfestani, et al.
Neuropharmacology|April 2, 2017
Amylin receptor ligands reduce the pathological cascade of Alzheimer's diseaseHaihao Zhu, Xiehua Xue, Erming Wang, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2011
Local RNA translation at the synapse and in diseaseLiqun Liu-Yesucevitz, Gary J Bassell, Aaron D Gitler, et al.
Cellular Signalling|January 16, 2010
Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathwayIria Carballo-Carbajal, Susanne Weber-Endress, Giorgio Rovelli, et al.
Nature Communications|January 13, 2016
Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's diseaseQingde Zhou, Allen Yen, Grzegorz Rymarczyk, et al.
Molecular Neurodegeneration|March 20, 2008
Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor proteinCelina V Zerbinatti, Joanna M Cordy, Ci-Di Chen, et al.
Science Advances|February 1, 2023
Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stressLulu Jiang, Pijush Chakraborty, Lushuang Zhang, et al.
Frontiers in Neuroscience|April 25, 2020
Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in TauopathyChelsey Jenna LeBlang, Maria Medalla, Nicholas William Nicoletti, et al.
Neuron|December 24, 2002
Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neuronsLeonard Petrucelli, Casey O'Farrell, Paul J Lockhart, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2024
GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease-like filamentsPijush Chakraborty, Alain Ibáñez de Opakua, Jeffrey A Purslow, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Nanobodies targeting hnRNPA2/B1 and tauAzady Pirhanov, Cristian Rodriguez, Fatemeh Tashakori-Asfestani, et al.
Neuropharmacology|April 2, 2017
Amylin receptor ligands reduce the pathological cascade of Alzheimer's diseaseHaihao Zhu, Xiehua Xue, Erming Wang, et al.
Pageof 13